Urovant Sciences
Manufacturing · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
5281 California Ave Ste 100, Irvine, Cal...Phone Number
(949) 226-6029Website
www.urovant.comRevenue
$19.9 MillionIndustry
About Urovant Sciences
Sumitomo Pharma America, Inc. focuses on advancing innovative treatments in oncology, women's health, urology, rare diseases, and CNS to enhance patient lives. The company is dedicated to addressing critical patient needs through drug discovery, development, and commercialization, emphasizing efficiency and meaningful innovation. With a diverse pipeline of preclinical and clinical programs, SMPA aims to deliver better experiences for patients and caregivers. Their commitment to scientific rigor and patient-first values drives their mission to improve global health and well-being.Explore more
SIC Code 28,283NAICS Code 32,325Show moreUrovant Sciences Org Chart
Compare Similar Companies to Urovant Sciences
Compare insights from companies similar to Urovant Sciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Urovant Sciences
$19.9M
51-200
Private
$300M
2016
RC
Ryan CarteExecutive Vice President & General Counsel & Corporate Secretary
Urovant Sciences Tech Stack
A closer look at the technologies used by Urovant Sciences
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Urovant Sciences
Sign Up For FreeTo access detailed company insights
Sumitomo Pharma America, Inc. focuses on advancing innovative treatments in oncology, women's health, urology, rare diseases, and CNS to enhance patient lives. The company is dedicated to addressing critical patient needs through drug discovery, development, and commercialization, emphasizing efficiency and meaningful innovation. With a diverse pip... Read More